Chemicals

(1R,2R,4R)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-hydroxycyclopentane carboxylic acid

We are (1R,2R,4R)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-hydroxycyclopentane carboxylic acid CAS:922727-92-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 922727-92-2

Product Name: (1R,2R,4R)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-hydroxycyclopentane carboxylic acid

Other Name:

(1R,2R,4R)-2-[5-Hexen-1-yl(methyl)carbamoyl]-4-hydroxycyclopentanecarboxylic acid

(1R,2R,4R)-2-(hex-5-enyl-methyl-carbamoyl)-4-hydroxy-cyclopentanecarboxylic acid

Density: 1.2±0.1 g/cm3

Boiling Point: 480.1±45.0 °C at 760 mmHg

Molecular Formula: C14H23NO4

Molecular Weight: 269.337

Flash Point: 244.2±28.7 °C

Exact Mass: 269.162720

PSA: 77.84000

LogP: 0.38

Vapour Pressure: 0.0±2.7 mmHg at 25°C

Index of Refraction: 1.530

Specification

Assay: ≥99.0%

Loss on drying: ≤0.5%

Application

Intermediates of Simeprevir CAS: 923604-59-5.

Be used as pharmaceutical intermediate, mainly used to synthesize antihepatitis C drugs Simeprevir.

Package: 25kg/drum, can also be designed according to customer requirements.

Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

(1R,2R,4R)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-hydroxycyclopentane carboxylic acid

Related News: The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.536760-29-9 The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.Catechol CAS:120-80-9 The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.(3S, 4R) -4-Acetoxi-3 – [(R) -1- (terc-butildimetilsililoxi) etil] azetidin-2-ona CAS:76855-69-1 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.

Product Name
kojic acid Cas:501-30-4	View Details
4,4′-biphenyldicarbonyl chloride Cas:2351-37-3	View Details
2-hydroxy-4-amino butanoic acid Cas:13477-53-7	View Details